Fresenius SE & Co. KGaA is a European health care company based in Bad Homburg, Germany. The North American branch of Fresenius Medical Care is headquartered in Waltham, Massachusetts. The Fresenius Group provides products and services for dialysis, hospitals as well as inpatient and outpatient medical care. In addition, the company focuses on hospital management as well as on engineering and services for medical centers and other health care facilities.
The Fresenius Group is made up of four divisions:
Fresenius Medical Care (a publicly traded company of which Fresenius owns 30.8%) focuses on patients with chronic kidney failure.
Fresenius Helios is Germany’s largest hospital operator.
Fresenius Kabi is a supplier of essential drugs, clinical nutrition products and medical devices.
Fresenius Vamed plans, develops and manages healthcare facilities.
Another arm of Fresenius Kabi is Fresenius Kabi Oncology Plc. It produces generics of intravenous oncology products such as Paclitaxel, Irinotecan, Oxaliplatin, Gemcitabine, Cytarabine, Carboplatin, Topotecan, Docetaxel and Epirubicin.
Fresenius owns the Helios Kliniken, which has more than 110 hospitals and more than 30,000 beds, treating over 4 million patients annually. The hospital operator is the biggest provider of inpatient and outpatient care in Germany.
In 2016 Fresenius bought the largest Spanish hospital group, the Grupo Hospitalario Quirónsalud for 5.76 Billion euros and merged it into the Helios Group, establishing the biggest hospital group of Europe.
KEYDION provides services and supports for document translations of Fresenius Medical Care. Working for a health care company, we had to ensure that our translated materials would be clear, concise and reflective of the medical terminology. Since the collaboration between KEYDION and Fresenius Medical Care, we has solved many medical and technical document translation problems for Fresenius Medical Care and has provided strong support for the translations of medical and technical documents into German, English and Chinese. With the high-quality of translations, KEYDION has acquired the excellent praise of Fresenius medical headquarters in Germany.
The Fresenius Group is made up of four divisions:
Fresenius Medical Care (a publicly traded company of which Fresenius owns 30.8%) focuses on patients with chronic kidney failure.
Fresenius Helios is Germany’s largest hospital operator.
Fresenius Kabi is a supplier of essential drugs, clinical nutrition products and medical devices.
Fresenius Vamed plans, develops and manages healthcare facilities.
Another arm of Fresenius Kabi is Fresenius Kabi Oncology Plc. It produces generics of intravenous oncology products such as Paclitaxel, Irinotecan, Oxaliplatin, Gemcitabine, Cytarabine, Carboplatin, Topotecan, Docetaxel and Epirubicin.
Fresenius owns the Helios Kliniken, which has more than 110 hospitals and more than 30,000 beds, treating over 4 million patients annually. The hospital operator is the biggest provider of inpatient and outpatient care in Germany.
In 2016 Fresenius bought the largest Spanish hospital group, the Grupo Hospitalario Quirónsalud for 5.76 Billion euros and merged it into the Helios Group, establishing the biggest hospital group of Europe.
KEYDION provides services and supports for document translations of Fresenius Medical Care. Working for a health care company, we had to ensure that our translated materials would be clear, concise and reflective of the medical terminology. Since the collaboration between KEYDION and Fresenius Medical Care, we has solved many medical and technical document translation problems for Fresenius Medical Care and has provided strong support for the translations of medical and technical documents into German, English and Chinese. With the high-quality of translations, KEYDION has acquired the excellent praise of Fresenius medical headquarters in Germany.